Aileron Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Aileron Therapeutics

Access the complete profile.

Aileron Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	738 Main Street Unit 398 Waltham, MA 02451

Note: Revenues for privately held companies are statistical evaluations.


Aileron Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aileron Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Aileron Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Aileron Therapeutics Annual Revenue and Growth Rate

Aileron Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aileron Therapeutics's revenues are gauged from an analysis of company filings.

Aileron Therapeutics's Income Statement (based on Industry Averages)

Aileron Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Aileron Therapeutics is developing and marketing. Aileron Therapeutics doesn't have any recent trademark applications, indicating Aileron Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
STAPLED PEPTIDE pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes	08/21/2009
AILERON pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes	02/15/2007

See all trademarks and details in the Full Report.

Market Share of Aileron Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aileron Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Aileron Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELEVATEBIO IPSC	Waltham, MA	100
IMMUNOGEN	Waltham, MA	36
BOSTON IVF	Waltham, MA	34
NPS PHARMACEUTICALS	Lexington, MA	32
CLINICAL SERVICES CORPORATE OPERATIONS	Waltham, MA	20
FOSTER-MILLER	Waltham, MA	15

Future Competition: Aileron Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Aileron Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)